3 June 2020

Patholytix Preclinical 1.4 with Work from Home Mode

We understand that many of our partners now face changing work practices and are more reliant now than ever on remote collaborative tools to manage their day to day operations. Our team remains as committed and as capable as ever to supporting you, and to help you protect business continuity.

scanning equipment

The new release of Patholytix Preclinical 1.4 is optimised for the home office environment. We have implemented strategies to enable our users to fully work from home to eliminate any business continuity issues arising from changing working practices. We have also incorporated Home user licencing models to facilitate more distributed work practices as required in the current climate. We are facilitating Direct-to-home shipment of high specification laptops and peripherals to enable users work where they are and have introduced a High-performance scanning service in Chicago to mitigate accessibility and scanning throughput issues being experienced by customers.  Patholytix Preclinical 1.4 also includes a myriad of other features requested by our partners to make the experience of using the product even better. 

Key to this is an accelerated and streamlined process for data integration.  Introducing barcode support in the workflow allows for continuous image integration from scanner to remote user. A combination of accelerated image integration process for industry leading formats and the introduction of new simplified data integration strategies makes getting the data you need to your stakeholders even easier. 

Patholytix AI also sees significant improvements from its initial release, faster and more flexible annotation strategies and optimised support for industry leading tablets, introduction of new models and loss functions, multi magnification AI, new augmentation strategies and accelerated training speeds. All of the above enhancements improves the performance of the platform to solve your problem of interest.

Commenting on the release, Dr Donal O’Shea, CEO of Deciphex says.

“This is a critical release for our user community to enable them to work effectively in these current times.  We really appreciate the efforts of the team to drive a release of this magnitude and impact for our customers.  To do so in such a short timescale demonstrates our responsiveness to both market conditions and customer feedback.” 
return to news

Contact Details

Invent Buidling at DCU

Ireland

Deciphex
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin

Call: +353 1 582 7193

Email: Info@deciphex.com

Twitter: @deciphex

USA Headquarters Building

USA

Deciphex Inc.
1012 95th Street, Naperville,
Chicago, Illinois

Call: +1 203 305 1675

Email: andrew.fink@deciphex.com

USA Headquarters Building

UK

Deciphex
Unit S04, Exeter Science Park Centre,
6 Babbage Way, Exeter

Call: +44 1 29730 2245

Email: Info@deciphex.com

Email Us

The details you submit will be used so that we can contact you in relation to your query either by email or your preferred method of contact. Read our privacy policy here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2021
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.